[{"NetIncomeLoss_1_Q3_USD":-21004000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":5572000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":18766000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":22938000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":15838000.0,"InterestPaidNet_3_Q3_USD":173000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-1045000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":186578000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":261883000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":1390000.0,"AssetsCurrent_0_Q3_USD":314100000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":14183000.0,"ContractWithCustomerLiability_0_Q3_USD":19343000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":1405378.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":1461000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":645000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":1349000.0,"CommonStockSharesIssued_0_Q3_shares":24473002.0,"Assets_0_Q3_USD":322520000.0,"ShareBasedCompensation_3_Q3_USD":3938000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":4862000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":5526998.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q3_USD":1300000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":1129949.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":261883000.0,"DepreciationAndAmortization_3_Q3_USD":613000.0,"OperatingLeaseLiability_0_Q3_USD":5353000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":33560000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":17699000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":6408000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":7335000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-339000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-66000.0,"AccountsReceivableNetCurrent_0_Q3_USD":2447000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"CommonStockValue_0_Q3_USD":25000.0,"DepreciationAndAmortization_1_Q3_USD":200000.0,"ContractWithCustomerAssetNet_0_Q3_USD":2447000.0,"InterestExpenseLongTermDebt_1_Q3_USD":200000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":272944000.0,"DeferredRevenueNoncurrent_0_Q3_USD":13645000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-41044000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-21004000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":15000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":307023000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":4155000.0,"Liabilities_0_Q3_USD":60890000.0,"Dividends_3_Q3_USD":0.0,"InterestExpenseLongTermDebt_3_Q3_USD":700000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":496000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":1432000.0,"RestrictedCashNoncurrent_0_Q3_USD":107000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":7301000.0,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":-263000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":2794000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q3_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":3938000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":1988000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-36229000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":1427000.0,"LiabilitiesCurrent_0_Q3_USD":28014000.0,"CommonStockSharesOutstanding_0_Q3_shares":24473000.0,"DeferredRevenueCurrent_0_Q3_USD":5698000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":307130000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":1461000.0,"LongTermDebtNoncurrent_0_Q3_USD":15076000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.084,"AdditionalPaidInCapital_0_Q3_USD":374317000.0,"NumberOfOperatingSegments_3_Q3_Segment":1.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q3_USD":7500000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":670000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":3451000.0,"NetIncomeLoss_3_Q3_USD":-41044000.0,"AccountsPayableCurrent_0_Q3_USD":6478000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":1055000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":268000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-112712000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":3872000.0,"CommonStockSharesAuthorized_0_Q3_shares":30000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":7301000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":2333000.0,"OperatingIncomeLoss_3_Q3_USD":-40442000.0,"OperatingIncomeLoss_1_Q3_USD":-20938000.0,"OperatingLeaseCost_3_Q3_USD":1300000.0,"OperatingLeaseCost_1_Q3_USD":500000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":322520000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":3099000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":235670000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q3_USD":6500000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":1988000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":6245000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1198000.0,"OperatingExpenses_3_Q3_USD":47743000.0,"OperatingExpenses_1_Q3_USD":23271000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":674000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-2.19,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.92,"StockholdersEquity_0_Q3_USD":261630000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1045000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":3938000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-4236000.0,"Ticker":"ARCT","CIK":"1768224","name":"ARCTURUS THERAPEUTICS HOLDINGS INC.","OfficialName":"Arcturus Therapeutics Holdings Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"666232551.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201109"}]